Anxiety Disorders Clinical Trial
— UP-COfficial title:
Emotion Detectives - Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children: A Randomized Controlled Trial in the Portuguese Population
Verified date | October 2023 |
Source | University of Coimbra |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) is a transdiagnostic and emotion-focused cognitive-behavioral group intervention for children aged 6-12 years old with emotion disorders (i.e., anxious and/or mood disorders) and their parents. UP-C consists of 15 weekly group sessions and unifies cognitive-behavioral, contextual (e.g., mindfulness) and parental training techniques, for parents and children, aimed at reducing the intensity and frequency of strong and aversive emotional experiences in children and their clinical symptomatology. The present study aims to assess the feasibility, acceptability and efficacy of the UP-C in the Portuguese population in reducing children's anxiety/depression symptoms. It also aims to investigate which mechanisms explain the therapeutic change. Participants will be recruited at child mental health services and schools from Central Portugal and also through online dissemination of the study. A randomized controlled trial (RCT) will be conducted in a sample of children aged 6-13 years old with emotional disorders and their parents in order to answer the critical question of whether the UP-C is more efficacious in reducing children's symptomatology than a psychoeducational group intervention (active control group). Once the eligibility criteria are met (assessed by the project researchers) parents and children will be randomly assigned to one of two study conditions: 1. experimental group (i.e., children and parents who benefit from the UP-C program). 2. control group (i.e., children who benefit from a psychoeducational intervention program, named "ABC of Emotions"). Parents and children from both groups will complete several psychometrically robust and developmentally appropriate measures at baseline (T0), mid-treatment (only at week 7 of the UP-C; T1), post treatment (T2) and at 3 months follow-up (T3).
Status | Completed |
Enrollment | 153 |
Est. completion date | November 30, 2022 |
Est. primary completion date | August 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 13 Years |
Eligibility | Inclusion Criteria: - Children aged 6-13 - Primary diagnosis of an anxiety and/or depression disorder - Speaking, reading and understanding Portuguese Exclusion Criteria: - Diagnosis of a psychotic disorder, bipolar disorder or intellectual disability; - Severe current suicidal/homicidal ideation; - The child is not on a stable dose of a psychotropic or other type of medication for at least 1 month prior to T0 assessment. |
Country | Name | City | State |
---|---|---|---|
Portugal | Faculty of Psychology and Education Sciences, University of Coimbra | Coimbra | Coimbra, Portugal |
Lead Sponsor | Collaborator |
---|---|
University of Coimbra | Centro Hospitalar Tondela-Viseu, Fundação para a Ciência e a Tecnologia |
Portugal,
Caiado B, Gois A, Pereira B, Canavarro MC, Moreira H. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) in Portugal: Feasibility Study Results. Int J Environ Res Public Health. 2022 Feb 4;19(3):1782. doi: 10.3390 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Feasibility of the program by adherence and dropout rate | Measured through the number of completers and users that dropped out from the intervention before completing it and through the involvement of the participants in the homework (through a record made at each session). | Póst-treatment (15 weeks) | |
Other | Acceptability of the program | Measured through specific questions (developed by the researchers) to assess acceptability of the program and to assess satisfaction for each session and for the global intervention - for parents and children; Measured by Parent Motivation Inventory - PMI (to measure parent motivation to participate in treatment). | Póst-treatment (15 weeks) | |
Primary | Changes of children's anxiety and depression | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | ||
Primary | Changes of children's severity of psychopathology and improvement | Measured with an adaptation of Clinical Global Impression (CGI). The CGI is composed by a severity of illness scale and a scale evaluating changes from the initiation of treatment. Higher scores are indicative of higher severity of psychopathology and lower improvement from the initiation of treatment. | Baseline, Póst treatment (15 weeks) | |
Secondary | Changes of child anxiety life interference | Measured by Child Anxiety Life Interference Scale - self-report (CALIS-C) and parent's report (CALIS-P). The child form is composed by a single scale and the parent form is composed by two subscales (Child Interference Subscale and Family Interference Subscale). Higher scores are indicative of greater interference of anxiety symptoms in the life of the children and the family. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of children's psychological flexibility | Measured by The Avoidance and Fusion Questionnaire - Youth (AFQ-Y). AFQ-Y assess children's psychological inflexibility, namely children's experiential avoidance and cognitive fusion. Higher scores are indicative of higher levels of children's psychological inflexibility. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of children's behavioral avoidance | Measured by Child- and Parent-Report Measures of Behavioral Avoidance Related to Childhood Anxiety Disorders (CAMS and CAMP). Higher scores are indicative of higher levels of children's behavioral avoidance. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of children's negative affect | Measured by Positive and Negative Affect for Children (PANAS-C). PANAS-C is composed by two independent subscales: Positive Affect and Negative Affect. Higher scores are indicative of higher levels of children's positive and negative affect, respectively. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of children's negative emotionality | Measured by School-Age Temperament Inventory (SATI). It is composed by five dimensions: negative emotionality, inhibition, adaptability, activity, and persistence. Only the subscale of negative emotionality is used in this study. Higher scores are indicative of higher levels of negative emotionality. | Baseline, Póst-treatment (15 weeks) | |
Secondary | Changes of children's anxiety sensitivity | Measured by Children's Anxiety Sensitivity Inventory-Revised (CASI-R). Higher scores are indicative of higher levels of anxiety sensitivity. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of children's tolerance of negative emotions | Measured by Distress Tolerance Scale (DTS). Higher scores are indicative of lower levels of tolerance to feel negative emotions. | Baseline, Mid-treatment (7 weeks), Póst treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of children's mindfulness skills | Measured by The Child and Adolescent Mindfulness Measure (CAMM). Higher scores are indicative of higher levels of children's mindfulness skills. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of children's negative cognitive error | Measured by Children's Negative Cognitive Error Questionnaire (CNCEQ). It assesses four types of cognitive errors derived theoretically: catastrophizing, overgeneralization, personalizing, and selective abstraction. CNCEQ yields a Total Score for each type of cognitive error, a Total Score for areas of content (social, academic, AtlĂ©tico) and a Total Score for cognitive errors. Higher values correspond to more cognitive errors. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of children's emotional expression and emotion awareness | Measured by Emotional Expression Scale for Children (EESC). Higher scores are indicative of higher levels of difficulties in children's emotional expression and emotion awareness. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of parent's anxiety and depression | Measured by Hospital Anxiety and Depression Scale (HADS). Higher scores are indicative of higher levels of anxiety and depression. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks) | |
Secondary | Changes of parental anxiety, parental overprotection and parental support of children's coping behaviors | Measured by Parental anxiety and overprotection scale (PAOS). Higher scores are indicative of higher levels of parental anxiety, parental overprotection and parental support of children's coping behaviors. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of parental neuroticism | Measured by NEO Five-Factor Inventory (NEO-FFI). It assesses the five traits of personality defined in the Five Factor Theory of Personality: Openness, Conscientiousness, Extraversion, Agreeableness and Neuroticism. In the present study only Neuroticism subscale was used. Higher scores are indicative of higher levels of neuroticism. | Baseline, Póst-treatment (15 weeks) | |
Secondary | Changes of parental inconsistency and permissiveness | Measured by Parenting Styles & Dimensions Questionnaire. Only the permissiveness subscale was used with higher scores being indicative of higher levels of parental inconsistency and permissiveness. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of parental criticism | Measured by EMBU-P (egna minnen beträffande uppfostran). It assesses four dimensions: emotional support, rejection, control attempt and sibling preference. In this study, only the rejection subscale was used, which assesses parental rejection and criticism. Higher scores indicate higher levels of rejection and parental criticism. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of shaping of negative emotions | Measured by The Parent Emotion Regulation Scale (PERS). It assesses four dimensions: parents' orientation to the child's emotions, parents' avoidance of the child's emotions, parents' lack of emotional control and parents' acceptance of the child's and their own emotions. In the present study only parents' lack of emotional control scale was used. This subscale assesses the lack of ability to modulate their own negative emotions in the presence of the child. Higher scores are indicative of higher levels of shaping of negative emotions. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months | |
Secondary | Changes of mindfulness in parenting | Measured by Interpersonal Mindfulness in Parenting Scale (IMP). Higher scores are indicative of higher levels of mindfulness in parenting. | Baseline, Mid-treatment (7 weeks), Póst-treatment (15 weeks), Follow-up 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03535805 -
Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Recruiting |
NCT05419934 -
EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial
|
N/A | |
Active, not recruiting |
NCT04136054 -
Better Sleep in Psychiatric Care - Anxiety and Affective Disorders
|
N/A | |
Completed |
NCT04091139 -
Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
|
Phase 2/Phase 3 | |
Completed |
NCT04647318 -
Physiological Response to Self-compassion Versus Relaxation
|
N/A | |
Active, not recruiting |
NCT05114824 -
Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students
|
N/A | |
Recruiting |
NCT05843695 -
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
|
N/A | |
Completed |
NCT05078450 -
Mood Lifters Online for Graduate Students and Young Professionals
|
N/A | |
Not yet recruiting |
NCT06162624 -
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
|
N/A | |
Not yet recruiting |
NCT05863637 -
Intensive Short-Term Dynamic Psychotherapy (ISTDP) for Anxiety Diagnoses in a Primary Care Setting
|
N/A | |
Not yet recruiting |
NCT05747131 -
Emotion Detectives In-Out: Feasibility and Efficacy of a Blended Version of the Unified Protocol for Children
|
N/A | |
Not yet recruiting |
NCT05225701 -
Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders.
|
N/A | |
Completed |
NCT02579915 -
Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)
|
N/A | |
Recruiting |
NCT02186366 -
Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type
|
N/A | |
Recruiting |
NCT02376959 -
Effect of Spiritist "Passe" Energy Therapy in Reducing Anxiety in Volunteers
|
N/A | |
Not yet recruiting |
NCT02126787 -
Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment
|
N/A | |
Completed |
NCT02134730 -
School-based Universal Prevention for Anxiety and Depression in Sweden: A Cluster-randomized Trial
|
N/A | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT01636791 -
CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
|
Phase 3 |